Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

News SummaryMost relevantAll newsSector news 

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
03/06/2012 | 04:35am CEST

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ASAHI KASEI CORP
07/21 ASAHI KASEI : "Woven Fabric" in Patent Application Approval Process (USPTO 20160..
07/21 ASAHI KASEI : "Incremental Delta-Sigma A/D Modulator and A/D Converter" in Paten..
07/15 ASAHI KASEI : Patent Application Titled "Current Sensor" Published Online (USPTO..
07/14 ASAHI KASEI : Patent Application Titled "Ultrafine Polyester Fiber" Published On..
07/11 AK7451 : Zero Latency Magnetic Rotary Angle Sensor for motor-driven applications..
07/11 ASAHI KASEI : Home Order Trends – June 2016
07/06 ASAHI KASEI : Pentagon taps Zoll Medical for $400M contract to provide vital sig..
07/01 ASAHI KASEI : Patent Issued for Sample Hold Circuit, A/D Converter, Calibration ..
06/30 ASAHI KASEI : Researchers Submit Patent Application, "Reaction Method Accompanie..
06/30 Federal Contracts Awarded to Companies in Massachusetts (June 30)
More news
Sector news : Commodity Chemicals - NEC
01:34pDJAIR PRODUCTS & CHEMICALS : Revenue Falls on Lower Energy Pass-Through
12:44pDJPRAXAIR : Revenue Slips, Narrows Yearly Guidance
08:13aDJLINDE : Lifts Profit Despite Pressure on Revenue
07/27 LYONDELLBASELL NV : U.S. judge revives $6.3 billion fraud claim in Lyondell bank..
07/27DJBayer Reports Higher Second-Quarter Profit, Raises Guidance
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
07/05 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
03/31 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
2015 Polypore merges with Asahi Kasei
2015 REGENERATIVE MEDICINE IN JAPAN : CJ Partners' Colin Lee Novick
2015 3M Co. Announces $1B Deal To Acquire Polypore Unit
Financials ( JPY)
Sales 2017 1 890 838 M
EBIT 2017 168 000 M
Net income 2017 88 783 M
Debt 2017 263 567 M
Yield 2017 2,59%
P/E ratio 2017 12,09
P/E ratio 2018 11,17
EV / Sales 2017 0,72x
EV / Sales 2018 0,67x
Capitalization 1 091 937 M
More Financials
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Full-screen chart
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 13
Average target price 840  JPY
Spread / Average Target 7,9%
Consensus details
EPS Revisions
More Estimates Revisions
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP-4.02%10 414
AIR LIQUIDE-SA ÉT.EXPL..-7.25%37 023
PRAXAIR, INC.15.57%33 758
AIR PRODUCTS & CHEMICA..14.53%32 198
More Results